The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses

被引:95
作者
Coates, MS
Fletcher, DF
Chan, HK [1 ]
Raper, JA
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Chem Engn, Sydney, NSW 2006, Australia
[3] Univ Missouri, Dept Chem Engn, Rolla, MO 65401 USA
基金
澳大利亚研究理事会;
关键词
CFD; computational fluid dynamics; DPI; dry powder aerosols; inhalation drug delivery;
D O I
10.1007/s11095-005-4587-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To study the fundamental effects of the spinning capsule on the overall performance of a dry powder inhaler (Aerolizer(R)). Methods. The capsule motion was visualized using high-speed photography. Computational fluid dynamics (CFD) analysis was performed to determine the flowfield generated in the device with and without the presence of different sized capsules at 60 l min(-1). The inhaler dispersion performance was measured with mannitol powder using a multistage liquid impinger at the same flowrate. Results. The capsule size (3, 4, and 5) was found to make no significant difference to the device flowfield, the particle-device impaction frequency, or the dispersion performance of the inhaler. Reducing the capsule size reduced only the capsule retention by 4%. In contrast, without the presence of the spinning capsule, turbulence levels were increased by 65%, FPFEm (wt% particles <= 6.8 mu m in the aerosol referenced against the amount of powder emitted from the device) increased from 59% to 65%, while particle-mouthpiece impaction decreased by 2.5 times. When the powder was dispersed from within compared to from outside the spinning capsule containing four 0.6 mm holes at each end, the FPFEm was increased significantly from 59% to 76%, and the throat retention was dropped from 14% to 6%. Conclusions. The presence, but not the size, of a capsule has significant effects on the inhaler performance. The results suggested that impaction between the particles and the spinning capsule does not play a major role in powder dispersion. However, the capsule can provide additional strong mechanisms of deagglomeration dependent on the size of the capsule hole.
引用
收藏
页码:923 / 932
页数:10
相关论文
共 16 条
[1]  
ADJEI AL, 1997, LUNG BIOL HEALTH DIS, V107, P625
[2]  
*BRIT PHARM, 2001, APP 12 AER ASS FIN P
[3]  
Chan HK, 2003, EXPERT OPIN THER PAT, V13, P1333, DOI 10.1517/eotp.13.9.1333.22942
[4]   The role of particle properties in pharmaceutical powder inhalation formulations [J].
Chew, NYK ;
Chan, HK .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2002, 15 (03) :325-330
[5]   Characterization of pharmaceutical powder inhalers: estimation of energy input for powder dispersion and effect of capsule device configuration [J].
Chew, NYK ;
Chan, HK ;
Bagster, DF ;
Mukhraiya, J .
JOURNAL OF AEROSOL SCIENCE, 2002, 33 (07) :999-1008
[6]  
CHEW NYK, 2002, ONLINE VERSION ENCY, P1
[7]   MEDICAL AEROSOL INHALERS - PAST, PRESENT, AND FUTURE [J].
CLARK, AR .
AEROSOL SCIENCE AND TECHNOLOGY, 1995, 22 (04) :374-391
[8]  
CLARK AR, 1996, RESP DRUG DELIVERY, V5, P221
[9]   Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length [J].
Coates, MS ;
Fletcher, DF ;
Chan, HK ;
Raper, JA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (11) :2863-2876
[10]  
Dunbar CA., 1998, KONA Powder Part J, V16, P7, DOI DOI 10.14356/KONA.1998007